Latest Sustainability In It News

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.

Turaco Gold has reported a significant 40% increase in its Afema Project gold resource to 3.55 million ounces, alongside promising high-grade drilling results and a robust $60 million capital raise to fund ongoing development.

Oakajee Corporation has progressed its gold exploration efforts at the Paynes Find project in Western Australia, preparing for drilling in the September quarter while maintaining a solid financial position.

Helios Energy has made significant strides in transitioning from exploration to production at its Presidio Project in Texas, supported by a $2.6 million capital raise and strategic U.S. hires. Early oil recovery and positive engagement with partners underscore its growing momentum.

The Calmer Co. International Limited reported a 6% quarterly revenue increase to $1.9 million in Q4 FY25, driving FY25 revenue to $8.0 million, an 86% year-on-year growth. Key channel expansions and cost efficiencies underpin its progress towards breakeven.

FlexiRoam Limited has achieved profitability in Q4 FY25, marking a significant turnaround with a positive EBITDA and net profit. Founder Jefrey Ong is appointed permanent CEO to steer the company’s next growth phase.

One Click Group Limited reported a 28% revenue increase to $1.3 million in H1 2025, launched a new $500 cash advance product, and surpassed 200,000 registered users, setting the stage for further growth.

Titanium Sands Limited has secured retention licenses for four critical exploration areas and is progressing its Environmental Impact Assessment in Sri Lanka, while engaging government officials and local landowners to navigate regulatory hurdles.

Lithium Universe Limited has secured global rights to a breakthrough solar panel recycling technology that promises to unlock vast reserves of critical minerals, while advancing its Québec lithium refinery with robust financials and strategic partnerships.

Amplia Therapeutics reports encouraging ACCENT trial results for its FAK inhibitor narmafotinib, including rare complete responses in pancreatic cancer, alongside a $27.5 million capital raise to fund ongoing clinical development.

Vection Technologies capped FY25 with its highest monthly order intake ever, driven by defence and AI/XR contracts, while posting positive pro-forma cash flow despite payment timing issues.

Fluence Corporation reports a robust 64.7% revenue increase in H1 2025, driven by strategic focus on higher-margin Smart Product Solutions and recurring revenue streams. The company maintains its FY2025 guidance, supported by a strong backlog and progress on a major Ivory Coast water project.